Replies to post #893 on ImmunoGen Inc (IMGN)

[shankapotamus]

Not when they’re selling truckloads of shares at $5.20 now. You must be new to the markets. Bless your heart. LOL

[vinmantoo]

Definitely will get bought out. Im thinking 30-40 and up to as high as 80’s with bidding wars.

It is nice to dream but it is way too soon to suggest such a price. IMGN needs to get Elahere full FDA approval in Europe, both of which are coming. The patients in MIRASOL were second line, on third line and even more heavily treated. Usage of Elahere in front line cancer would be better. Moreover, MIRASOL was a single agent trial and combination studies are underway. Elahere may have value in solid tumors as many express the alpha foliate receptor. Lastly, IMGN has other partnerships generating revenue, as well as several other wholly owned ADCs in trials.

This manuscript answer shows the expression of the alpha foliate receptor in solid tumors, which means there could be usage beyond ovarian cancer.

https://www.sciencedirect.com/science/article/pii/S0147027222000769


Lots of room for growth, and IMGN and its investors are in a great position scientifically as well as with regards to their cash on hand. It is also enjoyable to watch the shorts burn and spew their nasty and absurd comments here.